Opinion

Video

The Safety Profile of RAD-ENZ

Panelists discuss how the combination of radium-223 and enzalutamide (RAD-ENZ) demonstrated a manageable safety profile in PEACE-3, with bone health monitoring and prophylactic bone-targeted therapy being crucial considerations, particularly given the potential impact on future treatment options.

Video Player is loading.
Current Time 0:00
Duration 9:03
Loaded: 0%
Stream Type LIVE
Remaining Time 9:03
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Video content above is prompted by the following:

    • Can you discuss the safety profile of the combination of RAD-ENZ?
    • Keeping the safety profile of RAD-ENZ in mind, do you have any concerns about implementing the PEACE 3 protocol and introducing radium treatment as you are thinking about the possible need for future therapies?
    © 2025 MJH Life Sciences

    All rights reserved.